Clinical trial
Efficacy of Platelet-rich Plasma Versus Mesotherapy With Recombinant Growth Factors and Stem Cell Conditioned Media in Androgenetic Alopecia: A Retrospective Study.
NCT05129800 is registered in ClinicalTrials.gov with Faculty Hospital Kralovske Vinohrady as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Platelet-rich Plasma Versus Mesotherapy With Recombinant Growth Factors and Stem Cell Conditioned Media in Androgenetic Alopecia: A Retrospective Study.
- Lead sponsor
- Faculty Hospital Kralovske Vinohrady
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2011
- Completion date
- January 30, 2022
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia, androgenetic alopecia, hair loss